Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Jia

Showing results (411-420 of 422) with videos related to

Pageof 43
Sort By:
Annals of Surgical Oncology|February 13, 2026
Impact of Additional Resection on Outcomes in Patients with Positive Proximal Margin of Perihilar Cholangiocarcinoma: A Systematic Review and Network Meta-analysisDong-Liang Yang, Hao-Tian Ruan, Si-Qiao Shan, et al.
Cell Death Discovery|April 8, 2024
Thrombomodulin reduces α-synuclein generation and ameliorates neuropathology in a mouse model of Parkinson's diseaseXiao-Yun Niu, Xi-Xiu Xie, Hou-Zhen Tuo, et al.
Nature Materials|April 2, 2025
Giant nonlinear Raman responses from organic semiconductorsYi Jiang, He Lin, Jin-Qiang Pan, et al.
Anesthesiology|November 10, 2017
Targeted Genotyping Identifies Susceptibility Locus in Brain-derived Neurotrophic Factor Gene for Chronic Postsurgical PainYuanyuan Tian, Xiaodong Liu, Mingzhong Jia, et al.
Translational Lung Cancer Research|March 15, 2021
Identification of serum biomarkers to predict pemetrexed/platinum chemotherapy efficacy for advanced lung adenocarcinoma patients by data-independent acquisition (DIA) mass spectrometry analysis with parallel reaction monitoring (PRM) verificationBo Jia, Xinghui Zhao, Di Wu, et al.
Cancer Cell International|December 10, 2020
Prediction of the VeriStrat test in first-line therapy of pemetrexed-based regimens for advanced lung adenocarcinoma patientsBo Jia, Zhi Dong, Di Wu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 6, 2026
SMARCA4-deficient thoracic tumors exhibit an immunosuppressive microenvironment and respond to combined antiangiogenic and immune checkpoint inhibitor therapyPanpan Zhang, Yanbin Kuang, Bo Jia, et al.
Translational Lung Cancer Research|August 13, 2025
Prognostic significance of micropapillary pattern and risk factors in patients with resected stage I lung adenocarcinoma and possible benefit of adjuvant therapy: a real-world multicenter studyJianjie Li, Yujia Chi, Bo Jia, et al.
Ebiomedicine|March 26, 2025
Prevalence, genetic variations and clinical outcomes of BRAF-V600 mutated advanced NSCLC in China: a retrospective real-world multi-centre studyBo Jia, Shuo Wang, Fengyuan Zhang, et al.
Cell Host & Microbe|July 10, 2025
Lactate production by tumor-resident Staphylococcus promotes metastatic colonization in lung adenocarcinomaHuan Yu, Yang Du, Yuling He, et al.
Pageof 43

Showing results (411-420 of 422) with videos related to

Sort By:
Pageof 43
Annals of Surgical Oncology|February 13, 2026
Impact of Additional Resection on Outcomes in Patients with Positive Proximal Margin of Perihilar Cholangiocarcinoma: A Systematic Review and Network Meta-analysisDong-Liang Yang, Hao-Tian Ruan, Si-Qiao Shan, et al.
Cell Death Discovery|April 8, 2024
Thrombomodulin reduces α-synuclein generation and ameliorates neuropathology in a mouse model of Parkinson's diseaseXiao-Yun Niu, Xi-Xiu Xie, Hou-Zhen Tuo, et al.
Nature Materials|April 2, 2025
Giant nonlinear Raman responses from organic semiconductorsYi Jiang, He Lin, Jin-Qiang Pan, et al.
Anesthesiology|November 10, 2017
Targeted Genotyping Identifies Susceptibility Locus in Brain-derived Neurotrophic Factor Gene for Chronic Postsurgical PainYuanyuan Tian, Xiaodong Liu, Mingzhong Jia, et al.
Translational Lung Cancer Research|March 15, 2021
Identification of serum biomarkers to predict pemetrexed/platinum chemotherapy efficacy for advanced lung adenocarcinoma patients by data-independent acquisition (DIA) mass spectrometry analysis with parallel reaction monitoring (PRM) verificationBo Jia, Xinghui Zhao, Di Wu, et al.
Cancer Cell International|December 10, 2020
Prediction of the VeriStrat test in first-line therapy of pemetrexed-based regimens for advanced lung adenocarcinoma patientsBo Jia, Zhi Dong, Di Wu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 6, 2026
SMARCA4-deficient thoracic tumors exhibit an immunosuppressive microenvironment and respond to combined antiangiogenic and immune checkpoint inhibitor therapyPanpan Zhang, Yanbin Kuang, Bo Jia, et al.
Translational Lung Cancer Research|August 13, 2025
Prognostic significance of micropapillary pattern and risk factors in patients with resected stage I lung adenocarcinoma and possible benefit of adjuvant therapy: a real-world multicenter studyJianjie Li, Yujia Chi, Bo Jia, et al.
Ebiomedicine|March 26, 2025
Prevalence, genetic variations and clinical outcomes of BRAF-V600 mutated advanced NSCLC in China: a retrospective real-world multi-centre studyBo Jia, Shuo Wang, Fengyuan Zhang, et al.
Cell Host & Microbe|July 10, 2025
Lactate production by tumor-resident Staphylococcus promotes metastatic colonization in lung adenocarcinomaHuan Yu, Yang Du, Yuling He, et al.
Pageof 43